meta-analysis of serum tumor markers in lung cancer

Chinese Journal of Lung Cancer

Volumn 13, Issue 12, 2010, Pages 1136-1140

  Lu, Xianfeng ^a   Yang, Xueqin ^a   Zhang, Zhimin ^a   Wang, Dong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Lung neoplasms; Meta analysis; Tumor markers

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; DICKKOPF 1 PROTEIN; FERRITIN; TUMOR MARKER;

ARTICLE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; META ANALYSIS; SENSITIVITY AND SPECIFICITY;

HUMANS; LUNG NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650901916     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2010.12.11     Document Type: Article

References (15)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005, 55(2): 74-108.
2. Yu ZB, Han SP, Guo XR. Meta-analysis of the value of nuchal translucency as a screening test for fetal abnormalities in the first trimester ultrasound examination. Chin J Evid Based Pediatr, 2008, 3(6): 407-418.
3. Zamora J, Abraira W, Muriel A, et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol, 2006, 6: 31.
4. Kawachi R, Nakazato Y, Takei H, et al. Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembr-yonic antigen level predict pathological stage? Interact Cardiovasc Thorac Surg, 2009, 9(2): 199-202.
5. Hatzakis KD, Froudarakis ME, Bouros D, et al. Prognostic value of serum tumor markers in patients with lung cancer. Respiration, 2002, 69(1): 25-29. (Pubitemid 34158384)
6. Emin Erbaycu A, Gunduz A, Batum O, et al. Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study. Arch Bronconeumol, 2010, 46(7): 364-369.
7. Załeska M, Szturmowicz M, Zych J, et al. Elevated serum NSE level in locally advanced and metastatic NSCLC predispose to better response to chemotherapy but worse survival. Pneumonol Alergol Pol, 2010, 78(1): 14-20.
8. Holdenrieder S, von Pawel J, Dankelmann E, et al. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-Line chemotherapy of small cell lung cancer. Clin Cancer Res, 2008, 14(23): 7813-7821.
9. Racil H, Saad S, Rouhou SC, et al. The value of tumor markers in pulmonary tuberculosis. Tunis Med, 2009, 87(5): 330-333.
10. Sheng SL, Huang G, Yu B, et al. Clinical significance and prognostic value of serum dickkopf-1 concentrations in patients with lung cancer. Clin Chem, 2009, 55(9): 1656-1664.
11. Schneider J. Tumor markers in detection of lung cancer. Adv Clin Chem, 2006, 42: 1-41.
12. Weber DG, Johnen G, Taeger D, et al. Assessment of confounding factors affecting the tumor markers SMRP, CA125, and CYFRA21-1 in serum. Biomark Insights, 2010, 5: 1-8.
13. Liu YQ, Yu LQ, Lin JT. Study on the value of tumor markers ProGRP, CYFRA21-1, NSE and CEA in the differential diagnosis of pleural effusion. Chin J Lung Cancer, 2006, 9(3): 273-276.
14. Fuchs P, Loeseken C, Schubert JK, et al. Breath gas aldehydes as biomarkers of lung cancer. Int J Cancer, 2010, 126(11): 2663-2670.
15. Chon H, Lee S, Son SW, et al. Highly sensitive immunoassay of lung cancer marker carcinoembryonic antigen using surface-enhanced Raman scattering of hollow gold nanospheres. Anal Chem, 2009, 81(8): 3029-3034.